These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4032539)

  • 21. Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients.
    Minervini R; Minervini A; Fontana N; Traversi C; Cristofani R
    BJU Int; 2000 Aug; 86(3):199-202. PubMed ID: 10930914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
    Leibovich BC; Cheville JC; Lohse CM; Zincke H; Kwon ED; Frank I; Thompson RH; Blute ML
    J Urol; 2005 Mar; 173(3):716-9. PubMed ID: 15711250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can the Kattan nomogram still accurately predict prognosis in renal cell carcinoma using the revised 2010 tumor-nodes-metastasis reclassification?
    Veeratterapillay R; Rakhra S; El-Sherif A; Johnson M; Soomro N; Heer R
    Int J Urol; 2012 Aug; 19(8):773-6. PubMed ID: 22487261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
    Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma: survival and prognostic factors.
    Golimbu M; Joshi P; Sperber A; Tessler A; Al-Askari S; Morales P
    Urology; 1986 Apr; 27(4):291-301. PubMed ID: 3962052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.
    Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K
    World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma?
    Migliari R; Muscas G; Solinas A; Melis M; Ionta MT; Massidda B; Usai E
    J Chemother; 1995 Jun; 7(3):240-5. PubMed ID: 7562021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical care, morbidity, mortality and follow-up after nephrectomy for renal cancer with extension of tumor thrombus into the inferior vena cava: retrospective study since 1990s.
    Rigaud J; Hetet JF; Braud G; Battisti S; Le Normand L; Glemain P; Karam G; Bouchot O
    Eur Urol; 2006 Aug; 50(2):302-10. PubMed ID: 16759789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposal for reclassification of the TNM staging system in patients with locally advanced (pT3-4) renal cell carcinoma according to the cancer-related outcome.
    Ficarra V; Novara G; Iafrate M; Cappellaro L; Bratti E; Zattoni F; Artibani W
    Eur Urol; 2007 Mar; 51(3):722-9; discussion 729-31. PubMed ID: 16904819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
    Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
    J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
    Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
    J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma.
    Naito S; Kimiya K; Sakamoto N; Soejima T; Ueda T; Kumazawa J; Osada Y; Kurozumi T; Sagiyama K; Ariyoshi A
    Urology; 1991 Feb; 37(2):95-9. PubMed ID: 1992596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
    Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
    Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.
    Zisman A; Wieder JA; Pantuck AJ; Chao DH; Dorey F; Said JW; Gitlitz BJ; deKernion JB; Figlin RA; Belldegrun AS
    J Urol; 2003 Mar; 169(3):909-16. PubMed ID: 12576811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal cell carcinoma in children and adolescence: our experience.
    Kumar S; Sharma P; Pratap J; Tiwari P; Bera MK; Kundu AK
    Afr J Paediatr Surg; 2014; 11(2):101-4. PubMed ID: 24841006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.